14.09.2006 07:05:00
|
OMX: The Nordic Exchange Welcomes Genovis to First North in Sweden
Genovis AB is a life science provider company, which develops andmarkets a concept for delivering and studying the hereditarydisposition of living cells. Genovis' customers are life sciencecompanies and academic institutions developing new gene based drugs.Genovis was founded in 1999 and operates out of the IDEON Science Parkin Lund, Sweden.
"We warmly welcome Genovis to First North. Genovis is a valuablecontribution to our Health Care sector and the twenty-eighth companyto be listed on First North this year", says Jenny Rosberg, Presidentof Company Services.
Mangold Fondkommission AB is Certified Adviser for Genovis. Around lot of shares in Genovis, whose short name is GENO B, amounts to500 and the company is included in the Health Care sector.
About First North
First North is an alternative market with lighter requirementsthan OMX's main markets. It provides small growth companies with aworld of opportunities on the Nordic and global financial markets.First North is open for companies from all countries and offerslisting and trading in SEK, Euro or DKK and company disclosure inEnglish, Swedish, Danish or Norwegian. Investment in a company tradedon First North implies a higher risk than on the main market. FirstNorth in Sweden is operated by Stockholm Stock Exchange and FirstNorth in Denmark is operated by Copenhagen Stock Exchange. For moreinformation please visit www.omxgroup.com/firstnorth.
About OMX
OMX is a leading expert in the exchange industry. Through theNordic Exchange in Copenhagen, Stockholm, Helsinki, Riga, Tallinn andVilnius, OMX offers access to approximately 80 percent of the Nordicand Baltic securities market. Our integrated technology solutions spanthe entire transaction chain enabling efficient securitiestransactions for exchanges, clearing organizations, central securitiesdepositories and other financial institutions around the world. OMX islisted on the Nordic Exchange in Stockholm, Helsinki and Copenhagen.For more information please visit www.omxgroup.com
This information was brought to you by Waymakerhttp://www.waymaker.net

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Nasdaq Incmehr Nachrichten
20.02.25 |
S&P 500-Wert Nasdaq-Aktie: So viel hätten Anleger an einem Nasdaq-Investment von vor 10 Jahren verdient (finanzen.at) | |
13.02.25 |
S&P 500-Wert Nasdaq-Aktie: So viel Gewinn hätte ein Investment in Nasdaq von vor 5 Jahren abgeworfen (finanzen.at) | |
06.02.25 |
S&P 500-Wert Nasdaq-Aktie: So viel Gewinn hätte eine Investition in Nasdaq von vor 3 Jahren abgeworfen (finanzen.at) | |
30.01.25 |
S&P 500-Wert Nasdaq-Aktie: So viel hätten Anleger mit einem Investment in Nasdaq von vor einem Jahr verdient (finanzen.at) | |
28.01.25 |
Ausblick: Nasdaq verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net) | |
23.01.25 |
S&P 500-Wert Nasdaq-Aktie: So viel hätte eine Investition in Nasdaq von vor 10 Jahren abgeworfen (finanzen.at) | |
16.01.25 |
S&P 500-Wert Nasdaq-Aktie: So viel hätte eine Investition in Nasdaq von vor 5 Jahren abgeworfen (finanzen.at) | |
14.01.25 |
Erste Schätzungen: Nasdaq gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net) |
Analysen zu Nasdaq Incmehr Analysen
Aktien in diesem Artikel
Nasdaq Inc | 76,04 | -0,37% |
|